RVTY Value Scorecard - Revvity

Value Scorecard · run 2026-10-18

13 value checks: 12 scored 1 to 5, plus moat evidence

28/60

low-moderate value score

Earnings & returns

EPS Trend

1/5

Diluted EPS: $4.58 (2022), $5.55 (2023), $2.20 (2024), $2.07 (2025). The latest figure is half the 2022 figure or less; the framework scores that as 1.

ROE Trend

2/5

ROE (net income / common equity): 7.7% (2022), 8.8% (2023), 3.5% (2024), 3.3% (2025). Median 5.6%, lowest 3.3%; the framework scores a median 5-10% as 2.

ROIC

1/5

ROIC of 3.3%: operating income of $356.63M divided by $10.84B of capital (total assets $12.17B minus current liabilities $1.33B), fiscal year to Dec 28, 2025, as filed in the 10-K (SEC EDGAR). The framework scores below 5% as 1.

Profit Margins

3/5

Net margin of 8.2%; the framework scores 5-10% as 3; gross margin 55.0%, operating margin 17.1%.

Balance sheet & cash

Debt-to-Equity

4/5

Debt-to-equity of 0.46; the framework scores 0.3-0.8 as 4 (total debt $3.34B, total cash $1.02B).

Free Cash Flow

2/5

Free cash flow (operating cash flow minus capital expenditure): $594.18M (2022), $9.90M (2023), $541.65M (2024), $509.41M (2025). It ended at or below 2022; the framework scores that as 2.

Retained Earnings

5/5

Retained earnings, as filed in the 10-Ks (SEC EDGAR): $4.95B (2023), $5.61B (2023), $5.85B (2024), $6.05B (2025). It rose every year; the framework scores that as 5.

Valuation models

Graham IV

1/5

IV = EPS x (8.5 + 2g) x (4.4 / Y) = $2.09 x (8.5 + 2 x 0.0) x (4.4 / 4.5) = $17.37 (EPS CAGR -38.9% floored at 0%; the formula returns a negative value below -4.25% growth). Current price $152.64; price is 778.7% above the model value.

DCF Value

1/5

FCF/share = $5.422, stage 1 growth = 1.9% for 5 years, terminal growth = 3%, discount rate = 10%. Stage 1 PV = $21.68, PV of terminal value = $54.42, DCF value = $76.10. Current price $152.64; price is 100.6% above the model value.

Margin of Safety

1/5

Graham value $17.37 (price is 778.7% above the model value); DCF value $76.10 (price is 100.6% above the model value).

Price-to-Book

3/5

P/B of 2.36; the framework scores 1.5-3.0 as 3.

Business quality

Moat Evidence

Not scored

A moat (a brand, a network, switching costs, patents, scale, a licence) is not a number in the filings, so Valerius doesn’t score it. Below are the figures and the words moat analysis starts from, from the company’s own 10-K filings. The conclusion is yours.

Return on capital, each year

Above 15% in 0 of 10 years (2017-2025); lowest 2.5%, highest 13.7%.

Gross margin, each year

Between 47.6% and 79.2% over 7 years (a range of 31.6 points).

Competition, in the company’s own words · 10-K filed Feb 24, 2026

Due to the range and diversity of our products and services, we face many different types of competition and competitors. Our competitors range from foreign and domestic organizations, which produce a comprehensive array of goods and services and that may have greater financial and other resources than we do, to more narrowly focused firms producing a limited number of goods or services for specialized market segments.

The opening of the company’s “Competition” section in its 10-K, quoted word for word, not summarized or edited. It is the company’s own description, not Valerius’s view, and may include the company’s expectations. Open the filing.

Return on capital = operating income / (total assets − current liabilities), the ROIC row’s definition; 15% is the framework’s return threshold. Gross margin = gross profit / revenue. Both from each year’s 10-K via SEC EDGAR. Moat analysis commonly looks at whether returns and margins held up over many years. These figures don’t say whether the company has an advantage, what it is, or whether it will last.

Capital Allocation

4/5

Capital allocation, 2022-2025: dividends or buybacks paid in every year (pass); $1.80B paid out against $1.66B of free cash flow (fail: paid out more than free cash flow); total debt $4.60B to $3.40B, down 26.1%, 4.4x EBITDA (pass: not up more than 10%); shares outstanding 0.13B to 0.11B, down 11.1% (pass). 3 of 4 tests passed; the framework scores that as 4.

Filings

Company notices to the SEC

Not scored

Three kinds of event the company reported to the SEC in the last 5 years, from its filings on SEC EDGAR.

These are events the company reported to the SEC. An auditor change or a late filing can have many causes; each date links to the filing, where the company explains it. Valerius does not score these.

How the Graham and DCF values were calculated

  Graham Formula:
    IV = EPS x (8.5 + 2g) x (4.4 / Y)
    EPS = $2.09, g = 0.0%, Y = 4.5
    g floored at 0.0% (3-year EPS CAGR was -38.9%; below -4.25% the formula returns a negative value)
    IV = $17.37
    Current price $152.64 vs Graham value $17.37 — price is 778.7% above the model value.

  DCF:
    FCF/share = $5.422
    Stage 1 growth = 1.9% for 5 years | terminal growth = 3.0% | discount rate = 10.0%
      Y1: $5.525 → PV $5.023
      Y2: $5.630 → PV $4.653
      Y3: $5.737 → PV $4.310
      Y4: $5.846 → PV $3.993
      Y5: $5.957 → PV $3.699
    Stage 1 PV sum = $21.68
    Terminal value at end of Y5 = $87.65
    PV of terminal value = $54.42
    DCF value = $76.10
    Current price $152.64 vs DCF value $76.10 — price is 100.6% above the model value.

Data from yfinance summary figures and financial statements, and from the company’s 10-K filings via SEC EDGAR; computed at a price of $152.64. Every score is calculated from the figures by the framework’s fixed rules, and the explanation beside it is generated from the same figures: Graham value, DCF value, margin of safety, ROIC, profit margins, debt-to-equity, price-to-book, EPS trend, ROE trend, free cash flow, retained earnings and capital allocation. No AI is involved in this scorecard. The moat is shown as evidence, without a score. Read each score with the figures beside it. Intrinsic value calculations are model outputs based on stated assumptions, not predictions.

Recent headlines · third-party publishers · not investment advice

In the news

Loading headlines...

The 8 newest headlines whose title names the company, shown automatically and never chosen by Valerius. From third-party publishers via Yahoo Finance, linked to the source. Valerius doesn't write or endorse them. Not investment advice.

RVTY · Revvity

RVTY price